Susan Perry, NP
Women's Health · Fall River, MANPI 1780786038
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $478 and has fallen 74.0% since, to $124 in 2025. Among women's health clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $27.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$215
- AbbVie$180
- Pfizer$152
- Galderma Laboratories, L.p.$138
- Astellas Pharma US Inc$123
- Exeltis, USA Inc.$107
- plus $478 from 10 others
What the payments were for
- Food & beverage$1,37599%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 5 | $215 |
| AbbVie | 8 | $180 |
| Pfizer | 8 | $152 |
| Galderma Laboratories, L.p. | 2 | $138 |
| Astellas Pharma US Inc | 2 | $123 |
| Exeltis, USA Inc. | 5 | $107 |
| Agile Therapeutics, Inc. | 4 | $84 |
| Shield Therapeutics Inc | 4 | $74 |
| Organon | 3 | $72 |
| Aspira Women's Health Inc | 1 | $51 |
| Mayne Pharma Commercial LLC | 2 | $46 |
| Amgen | 2 | $43 |
| Mylan Pharmaceuticals Inc. | 2 | $40 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Coopersurgical, Inc. | 1 | $21 |
| Therapeuticsmd, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$125
How this compares
$1,392 in reported general payments places this provider in the 90th percentile of 141 women's health providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 25 | $1,851 |
Paid to pharmacies, not to this prescriber.
Other women's health in Fall River
- Deirdre CallahanFall River$562
- Gerri Berlin CohenHaverhill$81K
- Aisling LydeardRoxbury$20K
- Meghan BrideAuburndale$13K
- Stephanie LarrickDedham$4K
- Kristen KielySomerville$4K
- Jennifer TranAndover$3K
- Michelle MoynihanDartmouth$3K
- Rhonda GatelyBrockton$3K
- Suzanne RothBoston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.